Table 2. Characteristics of the febrile patients with S2 or S3 at presentation without comorbidities causing cytopenia (N = 130).
D1–D4 | D5–D6 | D8 | D11–D32 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diagnosis | N | D_fever (day) |
D_admission (day) |
Death (%) |
N | D_fever (day) |
D_admission (day) |
Death (%) |
N | D_fever (day) |
D_admission (day) |
Death (%) |
N | D_fever (day) |
D_admission (day) |
Death (%) |
Total N |
Upper respiratory infection | 49 | 2 (1–8) | 1 (1–79) | 0 | 3 | 5 (4–6) | 1 (1–1) | 0.0 | 8 | 8 (1–8) | 1 (1–2) | 0.0 | 5 | 1 (1–2) | 1 (1–1) | 0.0 | 65 |
Pneumonia | 14 | 1 (1–4) | 11 (1–135) | 21.4 | 1 | 3 | 2 | 100 | 3 | 15 (1–15) | 8 (2–14) | 33.3 | 18 | ||||
Urosepsis | 8 | 1 (1–3) | 10 (1–36) | 12.5 | 8 | ||||||||||||
Acute gastroenteritis | 5 | 1 (1–4) | 1 (1–6) | 0.0 | 1 | 1 | 1 | 0.0 | 6 | ||||||||
SFTS | 2 | 3.5 (3–4) | 10 (6–14) | 50.0 | 1 | 5 | 5 | 100 | 2 | 8 (8–8) | 9 (7–11) | 50.0 | 1 | 13 | 6 | 0.0 | 6 |
Drug fever | 2 | 3.5 (1–6) | 9 (7–11) | 0.0 | 1 | 1 | 1 | 0.0 | 1 | 1 | 66 | 0.0 | 4 | ||||
Intraabdominal infection | 2 | 1.5 (1–2) | 4.5 (2–7) | 0.0 | 1 | 5 | 22 | 0.0 | 3 | ||||||||
Heat stroke | 3 | 1 (1–1) | 1 (1–2) | 33.3 | 3 | ||||||||||||
Malaria, vivax | 1 | 15 | 6 | 0.0 | 1 | ||||||||||||
Adrenal insufficiency | 1 | 1 | 5 | 0.0 | 1 | ||||||||||||
Dengue | 1 | 4 | 8 | 0.0 | 1 | ||||||||||||
Acute viral hepatitis | 1 | 2 | 10 | 0.0 | 1 | ||||||||||||
Acute HIV syndrome | 1 | 8 | 1 | 0 | 1 | ||||||||||||
Undetermined | 8 | 1 (1–3) | 2 (1–9) | 0.0 | 2 | 6 (6–6) | 1 (1–1) | 0.0 | 2 | 6.0 (1–11) | 6.5 (5–8) | 0.0 | 12 | ||||
96 | 9 | 12 | 12 | 130 |
Statistics: The unit of values is median (range) for D_fever and D_admission. If the number of patients is only one, a single value is shown.
D, day of illness (D1 means 1st day of illness onset); D_fever, duration of fever at presentation (day); D_admission, duration of hospitalization (day); Death, in-hospital mortality (%).
SFTS, severe fever with thrombocytopenia syndrome; HIV, human immunodeficiency virus.